Abstract: Background: Knee proprioception is essential for injury prevention, stability, and performance improvement. Reliable proprioception measurement tools are crucial for accurate assessment and ...
In the latest automotive reliability report from Consumer Reports, Buick has emerged as the standard-bearer for American automakers. The brand secured a strong eighth-place finish overall in the 2026 ...
Chevrolet’s reliability story for 2026 is one of stark contrasts, landing the brand in a solidly average position in the latest Consumer Reports rankings. The brand’s overall score reflects a divided ...
Latin America’s outbound investment is surging, and a majority of that capital is staying within the region. In 2024, 65% of all outward FDI projects (by value) were directed toward other Latin ...
Purpose: This study aimed to use three statistical methods to investigate the inter-rater and intra-rater reliability of the Chinese version of the Short Orientation-Memory-Concentration Test (C-SOMC) ...
Sigmoid colon biopsy from a patient with treated ulcerative colitis showing chronic inflammation in the lamina propria and a focal area (black arrow in a) with intraepithelial and lamina propria ...
A recent study published in Housing Policy Debate, “Assessing the Reliability of SPDAT Homelessness Vulnerability Tools and the Impact of Assessor Consistency and Changes to Homeless Vulnerability ...
Objective To identify functional performance tests (FPTs) with potential to identify athletes at risk of lower extremity injury (LEI) and assess their measurement properties. Design Systematic review ...
Section 1. Purpose. The United States is experiencing an unprecedented surge in electricity demand driven by rapid technological advancements, including the expansion of artificial intelligence data ...
A literature review has confirmed that the Eczema Area and Severity Index (EASI) is an effective tool for measuring the severity and extent of atopic dermatitis (AD) -- including in patients with more ...
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback